These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8485264)

  • 1. Review article: immunosuppressive therapy for inflammatory bowel disease.
    Kozarek RA
    Aliment Pharmacol Ther; 1993 Apr; 7(2):117-23. PubMed ID: 8485264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive drugs in the treatment of inflammatory bowel disease.
    Aranda R; Horgan K
    Semin Gastrointest Dis; 1998 Jan; 9(1):2-9. PubMed ID: 9547850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
    Sandborn WJ
    Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
    [No Abstract]   [Full Text] [Related]  

  • 4. IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases.
    Meuwissen SG; Ewe K; Gassull MA; Geboes K; Jewell D; Pallone F; Rachmilewitz D; Rask-Madsen J; Riddell BH; Sandborn BJ; Schmuck ML
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):13-8. PubMed ID: 10656204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer treatments for inflammatory bowel disease.
    Stotland BR; Lichtenstein GR
    Prim Care; 1996 Sep; 23(3):577-608. PubMed ID: 8888346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of conventional immunosuppressive drugs in IBD.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Zippi M
    Dig Liver Dis; 2004 Nov; 36(11):766-80. PubMed ID: 15571009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory IBD: medical management.
    Tremaine WJ
    Neth J Med; 1997 Feb; 50(2):S12-4. PubMed ID: 9050327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive therapy in inflammatory bowel disease.
    Hoang P; Fontaine P; Dalton HR; Gehenot M; Sibille C; Schoonbroodt D; Vanheuverzwyn R
    Acta Gastroenterol Belg; 1994; 57(5-6):333-8. PubMed ID: 7709704
    [No Abstract]   [Full Text] [Related]  

  • 9. Review article: monitoring of immunomodulators in inflammatory bowel disease.
    Aberra FN; Lichtenstein GR
    Aliment Pharmacol Ther; 2005 Feb; 21(4):307-19. PubMed ID: 15709982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine.
    Bowen DG; Selby WS
    Dig Dis Sci; 2000 Sep; 45(9):1810-3. PubMed ID: 11052324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppressive therapy for inflammatory bowel disease: consensus by the Austrian working group on IBD].
    Reinisch W; Dejaco C; Knoflach P; Petritsch W; Vogelsang H; Tilg H
    Z Gastroenterol; 2004 Sep; 42(9):1033-45; discussion 1046-7. PubMed ID: 15455280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulator therapy of inflammatory bowel disease.
    Baert F; Rutgeerts P
    Acta Clin Belg; 1997; 52(5):251-7. PubMed ID: 9489118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive treatment for refractory ulcerative colitis--where do we stand and where are we going?
    Schölmerich J
    Eur J Gastroenterol Hepatol; 1997 Sep; 9(9):842-9. PubMed ID: 9355780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease.
    Ramakrishna J; Langhans N; Calenda K; Grand RJ; Verhave M
    J Pediatr Gastroenterol Nutr; 1996 Apr; 22(3):296-302. PubMed ID: 8708884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of methotrexate in an inflammatory bowel diseases based on the review of the current literature].
    Klimczak K; Łykowska-Szuber L; Krela-Kaźmierczak I; Eder P; Szymczak A; Stawczyk-Eder K; Linke K
    Wiad Lek; 2016; 69(2 Pt 2):262-6. PubMed ID: 27487545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Position statement: immunomodulator therapy for inflammatory Bowel disease.
    Lavy A; Chowers Y; Odes HS; Eliakim R;
    Isr Med Assoc J; 2003 Mar; 5(3):164-9. PubMed ID: 12725133
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing the therapeutic potential of azathioprine/6-mercaptopurine in the treatment of inflammatory bowel disease.
    Papadakis KA
    J Clin Gastroenterol; 2003; 36(5):379-81. PubMed ID: 12702974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.